Clinical Trial Update: Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by the University of Arkansas is exploring neurocognitive mechanisms behind smartphone-assisted strategies to prevent relapse i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Snippet

Sponsor: University of Arkansas | Conditions: Opioid-Related Disorders, Mobile Applications | Phase 2 | Status: RECRUITING